Abstract:Silver nanoparticles (AgNPs) and antimicrobial peptides or proteins (AMPs/APs) are both considered as promising platforms for the development of novel therapeutic agents effective against the growing number of drug-resistant pathogens. The observed synergy of their antibacterial activity suggested the prospect of introducing antimicrobial peptides or small antimicrobial proteins into the gelatinized coating of AgNPs. Conjugates with protegrin-1, indolicidin, protamine, histones, and lysozyme were comparatively tested for their antibacterial properties and compared with unconjugated nanoparticles and antimicrobial polypeptides alone. Their toxic effects were similarly tested against both normal eukaryotic cells (human erythrocytes, peripheral blood mononuclear cells, neutrophils, and dermal fibroblasts) and tumor cells (human erythromyeloid leukemia K562 and human histiocytic lymphoma U937 cell lines). The AMPs/APs retained their ability to enhance the antibacterial activity of AgNPs against both Gram-positive and Gram-negative bacteria, including drug-resistant strains, when conjugated to the AgNP surface. The small, membranolytic protegrin-1 was the most efficient, suggesting that a short, rigid structure is not a limiting factor despite the constraints imposed by binding to the nanoparticle. Some of the conjugated AMPs/APs clearly affected the ability of nanoparticle to permeabilize the outer membrane of Escherichia coli , but none of the conjugated AgNPs acquired the capacity to permeabilize its cytoplasmic membrane, regardless of the membranolytic potency of the bound polypeptide. Low hemolytic activity was also found for all AgNP-AMP/AP conjugates, regardless of the hemolytic activity of the free polypeptides, making conjugation a promising strategy not only to enhance their antimicrobial potential but also to effectively reduce the toxicity of membranolytic AMPs. The observation that metabolic processes and O 2 consumption in bacteria were efficiently inhibited by all forms of AgNPs is the most likely explanation for their rapid and bactericidal action. AMP-dependent properties in the activity pattern of various conjugates toward eukaryotic cells suggest that immunomodulatory, wound-healing, and other effects of the polypeptides are at least partially transferred to the nanoparticles, so that functionalization of AgNPs may have effects beyond just modulation of direct antibacterial activity. In addition, some conjugated nanoparticles are selectively toxic to tumor cells. However, caution is required as not all modulatory effects are necessarily beneficial to normal host cells.

Synthesis, characterization, mechanistic studies and antimicrobial efficacy of biomolecule capped and pH modulated silver nanoparticles

Synthesis, characterization, and antibacterial activity studies of β‐lactam capped silver nanoparticles

Membrane Penetrating-Cationic Peptide BP100 Functionalized Silver Nanoparticles as Efficient Antibacterial Agents

Antibacterial applications of biologically synthesized Pichia pastoris silver nanoparticles

Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles

Bacteriagenic silver nanoparticles: synthesis, mechanism, and applications

Biosynthesis of actinobacterial mediated silver nanoparticle (AgNPs): therapeutic potential and in-silico docking analysis on targeted virulence receptor

Assessment of Antibacterial Activity in Vitro Eco-Friendly Synthesis and Characterization of Silver Nanoparticles

Biosynthesis and Antibacterial Activity of Silver Nanoparticles Using Yeast Extract As Reducing and Capping Agents

Synthesis, characterization and antimicrobial activity of dextran stabilized silver nanoparticles in aqueous medium

Optimization for biogenic microbial synthesis of silver nanoparticles through response surface methodology, characterization, their antimicrobial, antioxidant, and catalytic potential

Silver Nanoparticles: Bactericidal and Mechanistic Approach against Drug Resistant Pathogens

Silver nanoparticles as an antimicrobial agent: A case study on Staphylococcus aureus and Escherichia coli as models for Gram-positive and Gram-negative bacteria.

Biosurfactant-based silver nanoparticles: Recent advances and their applications in antimicrobial drug resistance

Silver Nanoparticles Functionalized With Antimicrobial Polypeptides: Benefits and Possible Pitfalls of a Novel Anti-infective Tool

Synthesis, Characterization and Antimicrobial Activity of Bacillus subtilis-Derived Silver Nanoparticles Against Multidrug-Resistant Bacteria

Synthesis and characterization of maltol capped silver nanoparticles and their potential application as an antimicrobial agent and colorimetric sensor for cysteine

Exploring the Potential of Halotolerant Actinomycetes from Rann of Kutch, India: A Study on the Synthesis, Characterization, and Biomedical Applications of Silver Nanoparticles

Innovative synthesis and molecular modeling of actinomycetes-derived silver nanoparticles for biomedical applications

Novel Silver Nanoparticle-Antibiotic Combinations as Promising Antibacterial and Anti-biofilm Candidates against Multiple-Antibiotic Resistant ESKAPE Microorganisms

Synthesis, Characterization and Antimicrobial Study of Cinnamic Acid Functionalized Ag Nanoparticles